Tawnes, Judy Ann D.

HRN: 29-06-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2026
05/28/2026
IV
500mg
Q8hr X 6 Doses
Sp PLTCS, THICKLY MSAF
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines